Results 21 to 30 of about 1,405,405 (194)
Matthew L Stoll, Alisa C GotteDepartment of Pediatrics, Division of Rheumatology, UT Southwestern Medical Center, Dallas, TX, USAAbstract: Biologics have advanced the therapy of adult and pediatric arthritis. They have been linked to rare serious adverse
Matthew L Stoll, Alisa C Gotte
doaj +1 more source
Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA [PDF]
<b>Background</b>: Foot and ankle problems are a common but relatively neglected manifestation of juvenile idiopathic arthritis. Studies of medical and non-medical interventions have shown that clinical outcome measures can be improved ...
Sturrock, R.D. +35 more
core +1 more source
CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
The article presents a case of successful application of a monoclonal antibodies drug to interleukin 6 receptors (tocilizumab) at severe systemic juvenile idiopathic arthritis with the development of secondary hemophagocytic syndrome.
E. I. Alexeeva +3 more
doaj +1 more source
Juvenile-onset inflammatory arthritis: a study of adolescents' beliefs about underlying cause [PDF]
Objective. Patients’ beliefs regarding the cause of illness may influence treatment adherence and long-term outcome. Little is known of adolescents’ beliefs regarding the cause of JIA. This study aims to identify adolescents’ beliefs about the underlying
Baildam, Eileen +19 more
core +1 more source
Systemic Onset Juvenile Idiopathic Arthritis [PDF]
Systemic onset juvenile idiopathic arthritis, systemic JIA, sJIA, is a disease that develops before the age of 16 years and is active for at least 6 weeks.
Kolesnichenko A.A., Vasilyeva I.V.
doaj
CANAKINUMAB IN THE TREATMENT OF RHEUMATIC DISEASES IN CHILDREN
The article describes international multicenter controlled studies of efficacy and safety of monoclonal antibodies towards interleukin 1β — kanakinumab — when treating cryopyrin-associated periodic syndrome and systemic juvenile idiopathic arthritis in ...
Ye. I. Alekseeva, R. V. Denisova
doaj +1 more source
Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa [PDF]
Juvenile idiopathic arthritis (JIA) is defined as arthritis of unknown aetiology that begins before the 16th birthday and persists for at least 6 weeks, other conditions being excluded.
Weakley, Kate
core +1 more source
Pulmonary involvement in brucellosis: A case report and literature review
Although pulmonary involvement is rare in brucellosis it should be considered as a causative agent in patients with prolonged fever and arthritis. Also, it should be presented with manifestations resembling systemic juvenile idiopathic arthritis.
Maryam Abdollahi +3 more
doaj +1 more source
Introduction Differential diagnosis of the systemic juvenile idiopathic arthritis (sJIA) is often complicated, because of the variability in clinical presentation and the absence of specific signs.
Tetiana Kovalchuk, Oksana Boyarchuk
core +1 more source
Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease
Systemic-onset juvenile idiopathic arthritis (SoJIA), sometimes called Still’s disease, is a systemic inflammatory disease classified within the spectrum of juvenile idiopathic arthritis (JIA).
Rolando Cimaz +2 more
doaj +1 more source

